ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,85
0,00%
Bitcoin
60 972,76
1,10%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Neorx (MM) (NERX)

  7. Neorx (MM) (NERX) Actualités

NERX

Neorx (NERX)

Neorx (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NERX
DateHeureSourceTitreSymboleSociété
19/06/200614h30PR Newswire (US)Poniard Pharmaceuticals Announces Name Change Effective and Highlights Targeted Objectives for Picoplatin Clinical ProgramNASDAQ:NERX
07/06/200615h00PR Newswire (US)NeoRx Corporation (Poniard Pharmaceuticals) Announces Participation in Pacific Growth Equities 2006 Life Sciences Growth ConferNASDAQ:NERXNeorx (MM)
01/06/200615h00PR Newswire (US)Onmark Signs Contracts with Two Additional Pharmaceutical Manufacturers and Enrolls 1,800 MembersNASDAQ:NERX
31/05/200615h00PR Newswire (US)NeoRx Corporation (Poniard Pharmaceuticals) Announces Treatment of First Patient With Picoplatin in Phase 1/2 Front-Line ProstaNASDAQ:NERXNeorx (MM)
15/05/200623h15PR Newswire (US)NeoRx Corporation (Poniard Pharmaceuticals) Reports First Quarter Financial ResultsNASDAQ:NERXNeorx (MM)
10/05/200615h00PR Newswire (US)NeoRx Initiates Clinical Trial of Picoplatin in Colorectal Cancer and Announces Name Change to Poniard Pharmaceuticals and ReloNASDAQ:NERXNeorx (MM)
08/05/200615h00PR Newswire (US)NeoRx Announces Participation in Upcoming ConferencesNASDAQ:NERXNeorx (MM)
03/05/200615h00PR Newswire (US)NeoRx to Host Conference Call on May 10 to Provide Corporate and Picoplatin Clinical Development UpdatesNASDAQ:NERXNeorx (MM)
27/04/200615h00PR Newswire (US)NeoRx Closes $65 Million Financing TransactionNASDAQ:NERXNeorx (MM)
25/04/200619h30PR Newswire (US)NeoRx Shareholders Approve Financing TransactionNASDAQ:NERXNeorx (MM)
25/04/200615h00PR Newswire (US)NeoRx Expands Picoplatin Lung Cancer Clinical Trial Into Selected Eastern European CountriesNASDAQ:NERXNeorx (MM)
11/04/200619h13PR Newswire (US)NeoRx Adjourns Special Meeting of ShareholdersNASDAQ:NERXNeorx (MM)
08/03/200622h55PR Newswire (US)NeoRx Corporation's Auditors Expressed Going-Concern QualificationNASDAQ:NERXNeorx (MM)
07/03/200614h00PR Newswire (US)NeoRx Mails Definitive Proxy Statement for Special Shareholder Meeting Set for April 11, 2006NASDAQ:NERXNeorx (MM)
01/03/200622h15PR Newswire (US)NeoRx Reports Fourth Quarter and Full Year Financial ResultsNASDAQ:NERXNeorx (MM)
23/02/200614h00PR Newswire (US)NeoRx Corporation Regains Compliance With Nasdaq Minimum Bid Listing RequirementNASDAQ:NERXNeorx (MM)
02/02/200600h10PR Newswire (US)NeoRx Signs Definitive Agreement for $65 Million Private FinancingNASDAQ:NERXNeorx (MM)
12/01/200602h00PR Newswire (US)NeoRx Receives Notice From Nasdaq Regarding Minimum Bid Price RuleNASDAQ:NERXNeorx (MM)
10/11/200514h01PR Newswire (US)NeoRx Announces Orphan Drug Designation for Picoplatin for Treatment of Small Cell Lung CancerNASDAQ:NERXNeorx (MM)
09/11/200522h05PR Newswire (US)NeoRx Reports Third Quarter 2005 Financial ResultsNASDAQ:NERXNeorx (MM)
01/11/200514h01PR Newswire (US)NeoRx to Present at Rodman & Renshaw Techvest Healthcare ConferenceNASDAQ:NERXNeorx (MM)
11/10/200515h01PR Newswire (US)NeoRx to Present at BIO InvestorForum 2005NASDAQ:NERXNeorx (MM)
27/09/200523h11PR Newswire (US)NeoRx Corporation Regains Compliance with Nasdaq Minimum Bid Listing RequirementNASDAQ:NERXNeorx (MM)
09/08/200523h18PR Newswire (US)NeoRx Reports Second Quarter 2005 Financial ResultsNASDAQ:NERXNeorx (MM)
04/08/200514h30PR Newswire (US)NeoRx Joins The Scripps Research Institute in First Scientific Collaboration at Scripps FloridaNASDAQ:NERXNeorx (MM)
11/07/200516h56PR Newswire (US)NeoRx Announces Treatment of First Patient With Picoplatin in Phase 2 Clinical Trial in Small Cell Lung CancerNASDAQ:NERXNeorx (MM)
27/06/200515h00PR Newswire (US)NeoRx Appoints David A. Karlin, M.D., as Senior Vice President of Clinical Development and Regulatory AffairsNASDAQ:NERXNeorx (MM)
16/06/200515h01PR Newswire (US)NeoRx CEO to Participate in Break-Out Session at Upcoming BIO 2005 ConferenceNASDAQ:NERXNeorx (MM)
10/05/200523h05PR Newswire (US)NeoRx Reports First Quarter Financial ResultsNASDAQ:NERXNeorx (MM)
06/05/200523h15PR Newswire (US)NeoRx Refocusing Resources to Expedite Development of PicoplatinNASDAQ:NERXNeorx (MM)
 Showing the most relevant articles for your search:NASDAQ:NERX

Dernières Valeurs Consultées

COIN
ETHUSD
Ethereum
EU
MC
Lvmh Moet Hennessy Louis...
NASDAQ
AMZN
Amazon.com
NYSE
JPM
JP Morgan Chase
EU
GLE
Societe Generale
EU
AF
Air FranceKLM
USI
USTECH100
US Tech 100
EU
RI
Pernod Ricard
EU
DG
Vinci
EU
SGO
Cie de SaintGobain
NYSE
DIS
Walt Disney
EU
ORA
Orange
EU
BEL20
Bel 20
EU
HO
Thales
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés